Financhill
Sell
44

SKIN Quote, Financials, Valuation and Earnings

Last price:
$1.46
Seasonality move :
6.87%
Day range:
$1.45 - $1.59
52-week range:
$0.78 - $2.69
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.62x
P/B ratio:
2.84x
Volume:
299K
Avg. volume:
598.5K
1-year change:
-17.51%
Market cap:
$186.2M
Revenue:
$334.3M
EPS (TTM):
-$0.22

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
SKIN
The Beauty Health Co.
$77.7M -$0.05 -6.95% -66.08% $1.93
EWCZ
European Wax Center, Inc.
$47.6M $0.04 -4.36% -13.39% $6.68
GROV
Grove Collaborative Holdings, Inc.
$42.9M -$0.09 -13.41% -73.88% $2.00
KVUE
Kenvue, Inc.
$3.7B $0.23 1.17% 49.81% $19.33
SLSN
Solesence, Inc.
-- -- -- -- --
WALD
Waldencast Plc
$72.7M -$0.11 18.69% -- $3.16
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
SKIN
The Beauty Health Co.
$1.46 $1.93 $186.2M -- $0.00 0% 0.62x
EWCZ
European Wax Center, Inc.
$4.08 $6.68 $178.3M 15.64x $0.00 0% 0.84x
GROV
Grove Collaborative Holdings, Inc.
$1.23 $2.00 $50.9M -- $0.00 0% 0.26x
KVUE
Kenvue, Inc.
$16.83 $19.33 $32.2B 22.62x $0.21 4.9% 2.16x
SLSN
Solesence, Inc.
$1.51 -- $106.5M 107.86x $0.00 0% 1.74x
WALD
Waldencast Plc
$1.48 $3.16 $188.4M -- $0.00 0% 0.61x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
SKIN
The Beauty Health Co.
85.23% 4.579 149.6% 4.02x
EWCZ
European Wax Center, Inc.
83.03% 5.898 191.37% 2.95x
GROV
Grove Collaborative Holdings, Inc.
70.98% 2.204 24.28% 0.41x
KVUE
Kenvue, Inc.
46.14% -1.442 29.3% 0.58x
SLSN
Solesence, Inc.
59.38% 2.975 11.09% 0.66x
WALD
Waldencast Plc
20.1% 0.410 29.71% 0.53x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
SKIN
The Beauty Health Co.
$45.6M -$6.2M -2.13% -19.76% -8.84% $8.6M
EWCZ
European Wax Center, Inc.
$34.7M $14.3M 3.41% 16.45% 26.36% $16.5M
GROV
Grove Collaborative Holdings, Inc.
$23.3M -$2.7M -54.55% -151.59% -6.25% -$1.2M
KVUE
Kenvue, Inc.
$2.2B $713M 7.47% 13.85% 18.95% $196M
SLSN
Solesence, Inc.
$3.4M -$781K 2.86% 6.62% -5.35% -$2.9M
WALD
Waldencast Plc
-- -- -4.62% -5.64% -- --

The Beauty Health Co. vs. Competitors

  • Which has Higher Returns SKIN or EWCZ?

    European Wax Center, Inc. has a net margin of -15.61% compared to The Beauty Health Co.'s net margin of 9.91%. The Beauty Health Co.'s return on equity of -19.76% beat European Wax Center, Inc.'s return on equity of 16.45%.

    Company Gross Margin Earnings Per Share Invested Capital
    SKIN
    The Beauty Health Co.
    64.59% -$0.09 $444.6M
    EWCZ
    European Wax Center, Inc.
    63.98% $0.09 $487M
  • What do Analysts Say About SKIN or EWCZ?

    The Beauty Health Co. has a consensus price target of $1.93, signalling upside risk potential of 32.42%. On the other hand European Wax Center, Inc. has an analysts' consensus of $6.68 which suggests that it could grow by 63.81%. Given that European Wax Center, Inc. has higher upside potential than The Beauty Health Co., analysts believe European Wax Center, Inc. is more attractive than The Beauty Health Co..

    Company Buy Ratings Hold Ratings Sell Ratings
    SKIN
    The Beauty Health Co.
    1 6 0
    EWCZ
    European Wax Center, Inc.
    2 4 1
  • Is SKIN or EWCZ More Risky?

    The Beauty Health Co. has a beta of 1.162, which suggesting that the stock is 16.231% more volatile than S&P 500. In comparison European Wax Center, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock SKIN or EWCZ?

    The Beauty Health Co. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. European Wax Center, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Beauty Health Co. pays -- of its earnings as a dividend. European Wax Center, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SKIN or EWCZ?

    The Beauty Health Co. quarterly revenues are $70.7M, which are larger than European Wax Center, Inc. quarterly revenues of $54.2M. The Beauty Health Co.'s net income of -$11M is lower than European Wax Center, Inc.'s net income of $5.4M. Notably, The Beauty Health Co.'s price-to-earnings ratio is -- while European Wax Center, Inc.'s PE ratio is 15.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Beauty Health Co. is 0.62x versus 0.84x for European Wax Center, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SKIN
    The Beauty Health Co.
    0.62x -- $70.7M -$11M
    EWCZ
    European Wax Center, Inc.
    0.84x 15.64x $54.2M $5.4M
  • Which has Higher Returns SKIN or GROV?

    Grove Collaborative Holdings, Inc. has a net margin of -15.61% compared to The Beauty Health Co.'s net margin of -6.77%. The Beauty Health Co.'s return on equity of -19.76% beat Grove Collaborative Holdings, Inc.'s return on equity of -151.59%.

    Company Gross Margin Earnings Per Share Invested Capital
    SKIN
    The Beauty Health Co.
    64.59% -$0.09 $444.6M
    GROV
    Grove Collaborative Holdings, Inc.
    53.33% -$0.08 $29.7M
  • What do Analysts Say About SKIN or GROV?

    The Beauty Health Co. has a consensus price target of $1.93, signalling upside risk potential of 32.42%. On the other hand Grove Collaborative Holdings, Inc. has an analysts' consensus of $2.00 which suggests that it could grow by 62.6%. Given that Grove Collaborative Holdings, Inc. has higher upside potential than The Beauty Health Co., analysts believe Grove Collaborative Holdings, Inc. is more attractive than The Beauty Health Co..

    Company Buy Ratings Hold Ratings Sell Ratings
    SKIN
    The Beauty Health Co.
    1 6 0
    GROV
    Grove Collaborative Holdings, Inc.
    1 1 0
  • Is SKIN or GROV More Risky?

    The Beauty Health Co. has a beta of 1.162, which suggesting that the stock is 16.231% more volatile than S&P 500. In comparison Grove Collaborative Holdings, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock SKIN or GROV?

    The Beauty Health Co. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Grove Collaborative Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Beauty Health Co. pays -- of its earnings as a dividend. Grove Collaborative Holdings, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SKIN or GROV?

    The Beauty Health Co. quarterly revenues are $70.7M, which are larger than Grove Collaborative Holdings, Inc. quarterly revenues of $43.7M. The Beauty Health Co.'s net income of -$11M is lower than Grove Collaborative Holdings, Inc.'s net income of -$3M. Notably, The Beauty Health Co.'s price-to-earnings ratio is -- while Grove Collaborative Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Beauty Health Co. is 0.62x versus 0.26x for Grove Collaborative Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SKIN
    The Beauty Health Co.
    0.62x -- $70.7M -$11M
    GROV
    Grove Collaborative Holdings, Inc.
    0.26x -- $43.7M -$3M
  • Which has Higher Returns SKIN or KVUE?

    Kenvue, Inc. has a net margin of -15.61% compared to The Beauty Health Co.'s net margin of 10.58%. The Beauty Health Co.'s return on equity of -19.76% beat Kenvue, Inc.'s return on equity of 13.85%.

    Company Gross Margin Earnings Per Share Invested Capital
    SKIN
    The Beauty Health Co.
    64.59% -$0.09 $444.6M
    KVUE
    Kenvue, Inc.
    59% $0.21 $19.7B
  • What do Analysts Say About SKIN or KVUE?

    The Beauty Health Co. has a consensus price target of $1.93, signalling upside risk potential of 32.42%. On the other hand Kenvue, Inc. has an analysts' consensus of $19.33 which suggests that it could grow by 14.87%. Given that The Beauty Health Co. has higher upside potential than Kenvue, Inc., analysts believe The Beauty Health Co. is more attractive than Kenvue, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    SKIN
    The Beauty Health Co.
    1 6 0
    KVUE
    Kenvue, Inc.
    2 11 0
  • Is SKIN or KVUE More Risky?

    The Beauty Health Co. has a beta of 1.162, which suggesting that the stock is 16.231% more volatile than S&P 500. In comparison Kenvue, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock SKIN or KVUE?

    The Beauty Health Co. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kenvue, Inc. offers a yield of 4.9% to investors and pays a quarterly dividend of $0.21 per share. The Beauty Health Co. pays -- of its earnings as a dividend. Kenvue, Inc. pays out 150.5% of its earnings as a dividend.

  • Which has Better Financial Ratios SKIN or KVUE?

    The Beauty Health Co. quarterly revenues are $70.7M, which are smaller than Kenvue, Inc. quarterly revenues of $3.8B. The Beauty Health Co.'s net income of -$11M is lower than Kenvue, Inc.'s net income of $398M. Notably, The Beauty Health Co.'s price-to-earnings ratio is -- while Kenvue, Inc.'s PE ratio is 22.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Beauty Health Co. is 0.62x versus 2.16x for Kenvue, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SKIN
    The Beauty Health Co.
    0.62x -- $70.7M -$11M
    KVUE
    Kenvue, Inc.
    2.16x 22.62x $3.8B $398M
  • Which has Higher Returns SKIN or SLSN?

    Solesence, Inc. has a net margin of -15.61% compared to The Beauty Health Co.'s net margin of -7.67%. The Beauty Health Co.'s return on equity of -19.76% beat Solesence, Inc.'s return on equity of 6.62%.

    Company Gross Margin Earnings Per Share Invested Capital
    SKIN
    The Beauty Health Co.
    64.59% -$0.09 $444.6M
    SLSN
    Solesence, Inc.
    23.09% -$0.02 $42.4M
  • What do Analysts Say About SKIN or SLSN?

    The Beauty Health Co. has a consensus price target of $1.93, signalling upside risk potential of 32.42%. On the other hand Solesence, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that The Beauty Health Co. has higher upside potential than Solesence, Inc., analysts believe The Beauty Health Co. is more attractive than Solesence, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    SKIN
    The Beauty Health Co.
    1 6 0
    SLSN
    Solesence, Inc.
    0 0 0
  • Is SKIN or SLSN More Risky?

    The Beauty Health Co. has a beta of 1.162, which suggesting that the stock is 16.231% more volatile than S&P 500. In comparison Solesence, Inc. has a beta of 1.083, suggesting its more volatile than the S&P 500 by 8.259%.

  • Which is a Better Dividend Stock SKIN or SLSN?

    The Beauty Health Co. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Solesence, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Beauty Health Co. pays -- of its earnings as a dividend. Solesence, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SKIN or SLSN?

    The Beauty Health Co. quarterly revenues are $70.7M, which are larger than Solesence, Inc. quarterly revenues of $14.6M. The Beauty Health Co.'s net income of -$11M is lower than Solesence, Inc.'s net income of -$1.1M. Notably, The Beauty Health Co.'s price-to-earnings ratio is -- while Solesence, Inc.'s PE ratio is 107.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Beauty Health Co. is 0.62x versus 1.74x for Solesence, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SKIN
    The Beauty Health Co.
    0.62x -- $70.7M -$11M
    SLSN
    Solesence, Inc.
    1.74x 107.86x $14.6M -$1.1M
  • Which has Higher Returns SKIN or WALD?

    Waldencast Plc has a net margin of -15.61% compared to The Beauty Health Co.'s net margin of --. The Beauty Health Co.'s return on equity of -19.76% beat Waldencast Plc's return on equity of -5.64%.

    Company Gross Margin Earnings Per Share Invested Capital
    SKIN
    The Beauty Health Co.
    64.59% -$0.09 $444.6M
    WALD
    Waldencast Plc
    -- -- $896.6M
  • What do Analysts Say About SKIN or WALD?

    The Beauty Health Co. has a consensus price target of $1.93, signalling upside risk potential of 32.42%. On the other hand Waldencast Plc has an analysts' consensus of $3.16 which suggests that it could grow by 113.51%. Given that Waldencast Plc has higher upside potential than The Beauty Health Co., analysts believe Waldencast Plc is more attractive than The Beauty Health Co..

    Company Buy Ratings Hold Ratings Sell Ratings
    SKIN
    The Beauty Health Co.
    1 6 0
    WALD
    Waldencast Plc
    3 3 0
  • Is SKIN or WALD More Risky?

    The Beauty Health Co. has a beta of 1.162, which suggesting that the stock is 16.231% more volatile than S&P 500. In comparison Waldencast Plc has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock SKIN or WALD?

    The Beauty Health Co. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Waldencast Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Beauty Health Co. pays -- of its earnings as a dividend. Waldencast Plc pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SKIN or WALD?

    The Beauty Health Co. quarterly revenues are $70.7M, which are larger than Waldencast Plc quarterly revenues of --. The Beauty Health Co.'s net income of -$11M is higher than Waldencast Plc's net income of --. Notably, The Beauty Health Co.'s price-to-earnings ratio is -- while Waldencast Plc's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Beauty Health Co. is 0.62x versus 0.61x for Waldencast Plc. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SKIN
    The Beauty Health Co.
    0.62x -- $70.7M -$11M
    WALD
    Waldencast Plc
    0.61x -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify Stock a Good Buy Now?
Is Shopify Stock a Good Buy Now?

eCommerce technology platform Shopify (NASDAQ:SHOP) delivered impressive returns in 2025…

Will The Magnificent 7 Stocks Go Up This Year?
Will The Magnificent 7 Stocks Go Up This Year?

2025 was another banner year for the Magnificent Seven stocks,…

Why Did Planet Labs Stock Rally So Much?
Why Did Planet Labs Stock Rally So Much?

Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
100
ATGL alert for Jan 10

Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.

Buy
71
NAIL alert for Jan 10

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.

Buy
54
LGIH alert for Jan 10

LGI Homes, Inc. [LGIH] is up 13.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock